AnalystsKemp Dolliver
Kemp Dolliver's Stock Forecasts

Analyst Ranking
Bottom 7%
#4869 out of 5184 analysts
Average Return
-21.48%
Win Rate
27%4 out of 15
Risk vs Reward
Poor
Good

Kemp Dolliver's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Lisata Therapeutics IncLSTA
+69.63%$2.70$4.58
2025-07-14 -
2026-01-28
Strong Buy
Electrocore IncECOR
+36.26%$4.53$6.17
2023-01-12 -
2024-01-12
Strong Buy
Lantheus Holdings IncLNTH
+24.64%$71.62$89.27
2023-11-29 -
2024-11-29
Strong Buy
Radiopharm Theranostics LtdRADX
+16.71%$4.31$5.03
2025-07-20 -
2026-01-28
Strong Buy

Kemp Dolliver Analyst Color

Get additional color on Kemp Dolliver's coverage of popular stocks

Kemp Dolliver's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Verrica Pharmaceuticals IncVRCA
2Strong Buy$17.00+136.77%Upgrades
a month ago
Radiopharm Theranostics LtdRADX
1Strong Buy$18.00+257.85%Initiates Coverage On
6 months ago
Lisata Therapeutics IncLSTA
1Strong Buy$32.00+598.69%Maintains
6 months ago
Y Mabs Therapeutics IncYMAB
1Strong Buy$17.00N/AInitiates Coverage On
a year ago
Ibio IncIBIO
1Strong Buy$3.60N/AInitiates Coverage On
2 years ago
Dare Bioscience IncDARE
1Strong Buy$36.00N/AUpgrades
2 years ago
Outlook Therapeutics IncOTLK
1Strong Buy$31.40N/AUpgrades
2 years ago
Point Biopharma Global IncPNT
1Hold$12.50N/ADowngrades
2 years ago
Oncternal Therapeutics IncONCT
1Strong Buy$40.00N/AUpgrades
2 years ago
Lantheus Holdings IncLNTH
1Strong Buy$100.00N/AInitiates Coverage On
2 years ago
Hyperion Defi IncHYPD
1Strong Buy$640.00N/AInitiates Coverage On
2 years ago
Procaps Group SaPROCF
1Hold$4.50N/ADowngrades
2 years ago
Genelux CorpGNLX
1Hold$25.00N/AInitiates Coverage On
3 years ago
Electrocore IncECOR
1Strong Buy$18.75N/AInitiates Coverage On
3 years ago
Edesa Biotech IncEDSA
1Strong Buy$13.00N/AMaintains
3 years ago
Scynexis IncSCYX
1Strong Buy$8.00N/AAssumes
3 years ago
Icecure Medical LtdICCM
1Strong Buy$5.65N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.